Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Income Statement

Last quarter (Q ), Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue was zł14.30M, a decrease of -1.98% from the same quarter last year. In Q, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s net income was zł2.57M. See Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s key income statements, including revenue, expenses, profit, and income.